Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Mast Cells | 64 | 2025 | 1404 | 9.290 |
Why?
|
Asthma, Aspirin-Induced | 19 | 2024 | 204 | 6.380 |
Why?
|
Leukotrienes | 25 | 2025 | 232 | 5.370 |
Why?
|
Receptors, Leukotriene | 22 | 2025 | 97 | 5.240 |
Why?
|
Dinoprostone | 13 | 2024 | 591 | 3.300 |
Why?
|
Receptors, Purinergic P2 | 8 | 2022 | 149 | 2.690 |
Why?
|
Peanut Hypersensitivity | 6 | 2017 | 217 | 2.630 |
Why?
|
Cysteine | 16 | 2025 | 897 | 2.530 |
Why?
|
Hypersensitivity | 17 | 2025 | 1167 | 2.100 |
Why?
|
Immunoglobulin E | 18 | 2021 | 1479 | 2.030 |
Why?
|
Nasal Polyps | 10 | 2025 | 412 | 1.990 |
Why?
|
Aspirin | 17 | 2023 | 3135 | 1.960 |
Why?
|
Sinusitis | 10 | 2023 | 995 | 1.900 |
Why?
|
Leukotriene C4 | 6 | 2020 | 79 | 1.900 |
Why?
|
Asthma | 29 | 2025 | 6268 | 1.900 |
Why?
|
Leukotriene E4 | 13 | 2023 | 75 | 1.830 |
Why?
|
Blood Platelets | 9 | 2020 | 2464 | 1.780 |
Why?
|
National Institute of Allergy and Infectious Diseases (U.S.) | 11 | 2017 | 63 | 1.760 |
Why?
|
Food Hypersensitivity | 9 | 2017 | 734 | 1.560 |
Why?
|
Th2 Cells | 14 | 2024 | 1074 | 1.520 |
Why?
|
Interleukin-4 | 9 | 2023 | 1149 | 1.420 |
Why?
|
Leukotriene D4 | 7 | 2022 | 33 | 1.390 |
Why?
|
Antigens, Dermatophagoides | 7 | 2019 | 101 | 1.380 |
Why?
|
Eicosanoids | 7 | 2023 | 284 | 1.300 |
Why?
|
Eosinophils | 12 | 2017 | 946 | 1.250 |
Why?
|
Lung | 18 | 2024 | 10046 | 1.220 |
Why?
|
Platelet Activation | 5 | 2023 | 643 | 1.160 |
Why?
|
Receptors, Prostaglandin E, EP2 Subtype | 5 | 2024 | 48 | 1.130 |
Why?
|
Cyclooxygenase 1 | 4 | 2022 | 98 | 1.040 |
Why?
|
Pulmonary Eosinophilia | 6 | 2020 | 78 | 0.970 |
Why?
|
Pneumonia | 10 | 2024 | 2158 | 0.950 |
Why?
|
Mice, Knockout | 25 | 2024 | 14450 | 0.950 |
Why?
|
Lysophospholipids | 4 | 2011 | 335 | 0.930 |
Why?
|
Allergens | 10 | 2019 | 1435 | 0.920 |
Why?
|
Cytokines | 25 | 2024 | 7417 | 0.920 |
Why?
|
Nasal Mucosa | 5 | 2024 | 416 | 0.850 |
Why?
|
Inflammation | 20 | 2025 | 10843 | 0.810 |
Why?
|
Receptors, Purinergic P2Y12 | 4 | 2018 | 117 | 0.810 |
Why?
|
Alveolitis, Extrinsic Allergic | 1 | 2022 | 62 | 0.790 |
Why?
|
Respiratory Tract Diseases | 4 | 2021 | 744 | 0.780 |
Why?
|
Thromboxane A2 | 4 | 2015 | 87 | 0.760 |
Why?
|
NFATC Transcription Factors | 2 | 2022 | 391 | 0.750 |
Why?
|
Arachidonate 15-Lipoxygenase | 1 | 2022 | 84 | 0.750 |
Why?
|
Prostaglandins | 2 | 2023 | 396 | 0.740 |
Why?
|
Intramolecular Oxidoreductases | 4 | 2015 | 105 | 0.730 |
Why?
|
Rhinitis | 5 | 2023 | 752 | 0.730 |
Why?
|
Bronchial Hyperreactivity | 7 | 2017 | 300 | 0.720 |
Why?
|
Mastocytosis | 2 | 2022 | 150 | 0.710 |
Why?
|
Extracellular Signal-Regulated MAP Kinases | 5 | 2018 | 613 | 0.700 |
Why?
|
Prostaglandin D2 | 6 | 2016 | 108 | 0.700 |
Why?
|
Stem Cell Factor | 9 | 2011 | 194 | 0.660 |
Why?
|
Pyroglyphidae | 3 | 2015 | 93 | 0.640 |
Why?
|
Macrophages, Alveolar | 2 | 2019 | 413 | 0.640 |
Why?
|
Animals | 76 | 2025 | 168735 | 0.630 |
Why?
|
Autocrine Communication | 3 | 2013 | 167 | 0.620 |
Why?
|
Membrane Proteins | 11 | 2018 | 7847 | 0.610 |
Why?
|
Glutathione Transferase | 6 | 2017 | 562 | 0.600 |
Why?
|
Interleukin-13 | 6 | 2023 | 388 | 0.590 |
Why?
|
Interleukin-5 | 7 | 2020 | 268 | 0.590 |
Why?
|
Immune System Diseases | 2 | 2018 | 253 | 0.580 |
Why?
|
Cyclooxygenase Inhibitors | 2 | 2018 | 361 | 0.580 |
Why?
|
Mice | 52 | 2024 | 81782 | 0.580 |
Why?
|
Granulocytes | 3 | 2014 | 548 | 0.580 |
Why?
|
Signal Transduction | 23 | 2025 | 23597 | 0.570 |
Why?
|
HMGB1 Protein | 1 | 2019 | 139 | 0.570 |
Why?
|
Receptors, Prostaglandin E, EP4 Subtype | 1 | 2017 | 44 | 0.560 |
Why?
|
Cyclic AMP | 3 | 2017 | 1466 | 0.540 |
Why?
|
Leukotriene Antagonists | 6 | 2022 | 124 | 0.530 |
Why?
|
Cells, Cultured | 29 | 2024 | 18962 | 0.530 |
Why?
|
Purinergic P2Y Receptor Antagonists | 1 | 2018 | 284 | 0.500 |
Why?
|
Dietetics | 2 | 2017 | 34 | 0.500 |
Why?
|
Uridine Diphosphate | 3 | 2022 | 35 | 0.490 |
Why?
|
Paracrine Communication | 2 | 2007 | 277 | 0.490 |
Why?
|
Practice Guidelines as Topic | 5 | 2017 | 7423 | 0.480 |
Why?
|
Child Nutritional Physiological Phenomena | 1 | 2017 | 292 | 0.470 |
Why?
|
Receptors, Chemokine | 6 | 2007 | 651 | 0.470 |
Why?
|
Skin Tests | 4 | 2017 | 630 | 0.470 |
Why?
|
Tryptases | 6 | 2022 | 175 | 0.450 |
Why?
|
Epithelial Cells | 8 | 2024 | 3684 | 0.450 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 4 | 2023 | 3247 | 0.440 |
Why?
|
Inflammation Mediators | 3 | 2012 | 1886 | 0.440 |
Why?
|
Oxazoles | 1 | 2015 | 198 | 0.440 |
Why?
|
Mice, Inbred C57BL | 19 | 2024 | 22327 | 0.440 |
Why?
|
Macrophages | 8 | 2024 | 5772 | 0.430 |
Why?
|
Eosinophilia | 6 | 2017 | 553 | 0.420 |
Why?
|
Guanine Nucleotide Exchange Factors | 1 | 2017 | 571 | 0.420 |
Why?
|
Receptors, Lysophosphatidic Acid | 2 | 2011 | 78 | 0.420 |
Why?
|
Adaptive Immunity | 1 | 2018 | 733 | 0.410 |
Why?
|
Receptors, Interleukin-17 | 1 | 2013 | 82 | 0.410 |
Why?
|
Humans | 127 | 2025 | 765926 | 0.410 |
Why?
|
Respiratory Hypersensitivity | 2 | 2011 | 271 | 0.400 |
Why?
|
Chemokine CCL4 | 2 | 2013 | 124 | 0.400 |
Why?
|
Immune System | 3 | 2010 | 799 | 0.390 |
Why?
|
Basophils | 4 | 2014 | 392 | 0.380 |
Why?
|
Immunity, Cellular | 3 | 2006 | 1555 | 0.380 |
Why?
|
Receptors, Thromboxane | 3 | 2023 | 30 | 0.380 |
Why?
|
Fetal Blood | 9 | 2005 | 1365 | 0.370 |
Why?
|
Cyclooxygenase 2 Inhibitors | 1 | 2013 | 318 | 0.360 |
Why?
|
Thiophenes | 1 | 2015 | 570 | 0.360 |
Why?
|
Mycophenolic Acid | 1 | 2012 | 348 | 0.350 |
Why?
|
Stem Cells | 6 | 2022 | 3537 | 0.330 |
Why?
|
Immunity, Innate | 2 | 2015 | 3078 | 0.320 |
Why?
|
Primary Prevention | 1 | 2017 | 1187 | 0.320 |
Why?
|
Respiratory Mucosa | 3 | 2021 | 437 | 0.320 |
Why?
|
Vascular Cell Adhesion Molecule-1 | 4 | 2015 | 694 | 0.310 |
Why?
|
Tacrolimus | 1 | 2012 | 754 | 0.310 |
Why?
|
Homeostasis | 3 | 2023 | 3338 | 0.310 |
Why?
|
Antibodies, Anti-Idiotypic | 2 | 2009 | 340 | 0.310 |
Why?
|
Chemokines | 3 | 2009 | 956 | 0.300 |
Why?
|
Drug Hypersensitivity | 5 | 2019 | 903 | 0.290 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 2 | 2019 | 2270 | 0.290 |
Why?
|
Group V Phospholipases A2 | 3 | 2017 | 23 | 0.280 |
Why?
|
Dermatophagoides farinae | 2 | 2019 | 19 | 0.270 |
Why?
|
Anaphylaxis | 3 | 2011 | 738 | 0.270 |
Why?
|
Immune Tolerance | 2 | 2017 | 2324 | 0.270 |
Why?
|
Proto-Oncogene Proteins c-kit | 4 | 2011 | 723 | 0.270 |
Why?
|
T-Lymphocyte Subsets | 2 | 2013 | 1812 | 0.260 |
Why?
|
Interleukin-3 | 5 | 2001 | 423 | 0.260 |
Why?
|
Interleukin-4 Receptor alpha Subunit | 2 | 2024 | 57 | 0.260 |
Why?
|
Hypereosinophilic Syndrome | 2 | 2003 | 97 | 0.260 |
Why?
|
Cathepsin G | 2 | 2025 | 41 | 0.260 |
Why?
|
Receptors, Prostaglandin E | 1 | 2005 | 56 | 0.250 |
Why?
|
Myeloid Progenitor Cells | 1 | 2006 | 112 | 0.250 |
Why?
|
Histamine Release | 2 | 2021 | 117 | 0.250 |
Why?
|
Goblet Cells | 4 | 2020 | 300 | 0.250 |
Why?
|
Bronchoalveolar Lavage Fluid | 2 | 2019 | 755 | 0.240 |
Why?
|
Cell Differentiation | 10 | 2025 | 11639 | 0.240 |
Why?
|
Piperazines | 2 | 2015 | 2546 | 0.240 |
Why?
|
PPAR gamma | 1 | 2008 | 484 | 0.240 |
Why?
|
Evidence-Based Medicine | 1 | 2017 | 3690 | 0.240 |
Why?
|
Liver Transplantation | 2 | 2012 | 2418 | 0.240 |
Why?
|
Adenine Nucleotides | 1 | 2004 | 111 | 0.240 |
Why?
|
Urticaria | 1 | 2006 | 151 | 0.240 |
Why?
|
SRS-A | 1 | 2004 | 132 | 0.230 |
Why?
|
Lipids | 2 | 2013 | 3317 | 0.230 |
Why?
|
Lipoxygenase | 2 | 2022 | 71 | 0.230 |
Why?
|
Gene Expression Regulation | 7 | 2016 | 11895 | 0.230 |
Why?
|
Oncostatin M | 1 | 2024 | 42 | 0.230 |
Why?
|
MAP Kinase Kinase 1 | 1 | 2005 | 330 | 0.220 |
Why?
|
Arachidonic Acid | 2 | 2022 | 429 | 0.220 |
Why?
|
Lymphoid Enhancer-Binding Factor 1 | 1 | 2024 | 85 | 0.220 |
Why?
|
T Cell Transcription Factor 1 | 1 | 2024 | 72 | 0.220 |
Why?
|
Leukocytes | 1 | 2012 | 2027 | 0.220 |
Why?
|
Cyclooxygenase 2 | 2 | 2018 | 594 | 0.220 |
Why?
|
Ovalbumin | 3 | 2015 | 674 | 0.220 |
Why?
|
Thromboxanes | 1 | 2023 | 45 | 0.220 |
Why?
|
Mice, Mutant Strains | 4 | 2017 | 1748 | 0.210 |
Why?
|
Muscle, Smooth, Vascular | 1 | 2010 | 1494 | 0.210 |
Why?
|
Olfactory Mucosa | 1 | 2024 | 101 | 0.210 |
Why?
|
Picornaviridae Infections | 1 | 2024 | 97 | 0.210 |
Why?
|
Paranasal Sinuses | 1 | 2006 | 267 | 0.210 |
Why?
|
Lymphocyte Activation | 3 | 2013 | 5500 | 0.210 |
Why?
|
Hepatocyte Nuclear Factor 1-alpha | 1 | 2024 | 175 | 0.210 |
Why?
|
Hypersensitivity, Immediate | 2 | 2022 | 346 | 0.210 |
Why?
|
Interleukin-12 Subunit p40 | 1 | 2022 | 58 | 0.210 |
Why?
|
GTP-Binding Protein alpha Subunits, Gs | 1 | 2004 | 195 | 0.210 |
Why?
|
Allergy and Immunology | 2 | 2017 | 170 | 0.210 |
Why?
|
Rhinovirus | 1 | 2024 | 210 | 0.210 |
Why?
|
Quinolines | 4 | 2018 | 769 | 0.210 |
Why?
|
Multipotent Stem Cells | 1 | 2024 | 200 | 0.200 |
Why?
|
Cold Temperature | 1 | 2006 | 793 | 0.200 |
Why?
|
Mitosis | 1 | 2007 | 1175 | 0.200 |
Why?
|
Chemokines, CC | 2 | 2007 | 285 | 0.200 |
Why?
|
Prostaglandin-Endoperoxide Synthases | 2 | 2013 | 318 | 0.200 |
Why?
|
Nose | 1 | 2006 | 518 | 0.200 |
Why?
|
Cell Movement | 4 | 2017 | 5190 | 0.190 |
Why?
|
Male | 35 | 2024 | 363815 | 0.190 |
Why?
|
CHO Cells | 3 | 2012 | 1372 | 0.190 |
Why?
|
United States | 12 | 2017 | 72909 | 0.190 |
Why?
|
CD4-Positive T-Lymphocytes | 2 | 2011 | 4405 | 0.180 |
Why?
|
Bone Marrow Cells | 4 | 2021 | 2411 | 0.180 |
Why?
|
Cell Count | 3 | 2021 | 1823 | 0.180 |
Why?
|
Ligands | 3 | 2019 | 3272 | 0.180 |
Why?
|
Alternaria | 2 | 2017 | 41 | 0.180 |
Why?
|
Cricetinae | 3 | 2012 | 2412 | 0.180 |
Why?
|
Triazines | 1 | 2002 | 307 | 0.180 |
Why?
|
Interleukin-5 Receptor alpha Subunit | 1 | 2020 | 17 | 0.170 |
Why?
|
Integrins | 2 | 2012 | 838 | 0.170 |
Why?
|
Biological Evolution | 1 | 2006 | 1075 | 0.170 |
Why?
|
Receptors, Fc | 1 | 2003 | 537 | 0.170 |
Why?
|
Interleukin-12 Subunit p35 | 1 | 2019 | 22 | 0.170 |
Why?
|
Intercellular Adhesion Molecule-1 | 2 | 2015 | 1132 | 0.170 |
Why?
|
Cell Adhesion Molecules | 2 | 2006 | 1609 | 0.170 |
Why?
|
Cell Proliferation | 7 | 2024 | 10426 | 0.170 |
Why?
|
Receptors, IgE | 3 | 2011 | 374 | 0.170 |
Why?
|
Immunosuppressive Agents | 1 | 2012 | 4213 | 0.160 |
Why?
|
Transforming Growth Factor beta | 2 | 2025 | 1996 | 0.160 |
Why?
|
Dipeptidyl-Peptidase IV Inhibitors | 1 | 2023 | 317 | 0.160 |
Why?
|
Infant | 6 | 2021 | 36426 | 0.160 |
Why?
|
Hematopoietic Stem Cells | 4 | 2019 | 3405 | 0.160 |
Why?
|
Female | 34 | 2025 | 396141 | 0.160 |
Why?
|
Respiratory System | 2 | 2022 | 562 | 0.160 |
Why?
|
Receptors, CCR3 | 4 | 2003 | 61 | 0.160 |
Why?
|
Phospholipases A2, Cytosolic | 1 | 2018 | 3 | 0.160 |
Why?
|
Adenosine Diphosphate | 2 | 2013 | 419 | 0.160 |
Why?
|
Diet | 1 | 2017 | 8087 | 0.160 |
Why?
|
Enterocytes | 1 | 2020 | 220 | 0.160 |
Why?
|
Peptidyl-Dipeptidase A | 1 | 2020 | 323 | 0.150 |
Why?
|
Receptors, G-Protein-Coupled | 3 | 2022 | 1243 | 0.150 |
Why?
|
Cyclic AMP-Dependent Protein Kinases | 2 | 2014 | 484 | 0.150 |
Why?
|
Cell Lineage | 3 | 2021 | 2573 | 0.150 |
Why?
|
Exocytosis | 3 | 2005 | 323 | 0.150 |
Why?
|
beta 2-Microglobulin | 4 | 2001 | 330 | 0.140 |
Why?
|
Skin Irritancy Tests | 1 | 2017 | 4 | 0.140 |
Why?
|
Propionates | 3 | 2003 | 180 | 0.140 |
Why?
|
Laminin | 2 | 1996 | 404 | 0.140 |
Why?
|
Receptors, Lymphocyte Homing | 1 | 1997 | 141 | 0.140 |
Why?
|
Acetates | 1 | 2018 | 314 | 0.140 |
Why?
|
Consensus | 2 | 2017 | 3202 | 0.140 |
Why?
|
Mice, Inbred BALB C | 8 | 2015 | 6209 | 0.140 |
Why?
|
Arachidonate 5-Lipoxygenase | 2 | 2012 | 128 | 0.140 |
Why?
|
Interleukins | 1 | 2021 | 789 | 0.140 |
Why?
|
Biological Assay | 1 | 2019 | 626 | 0.130 |
Why?
|
Egg Hypersensitivity | 1 | 2017 | 47 | 0.130 |
Why?
|
Immunologic Factors | 1 | 2006 | 1590 | 0.130 |
Why?
|
Mice, Transgenic | 6 | 2021 | 9541 | 0.130 |
Why?
|
Recombinant Proteins | 7 | 2009 | 6491 | 0.130 |
Why?
|
Interferon Type I | 1 | 2020 | 567 | 0.130 |
Why?
|
Societies, Scientific | 1 | 2017 | 221 | 0.130 |
Why?
|
Virulence | 1 | 2019 | 1289 | 0.130 |
Why?
|
Receptors, Prostaglandin E, EP3 Subtype | 1 | 2015 | 23 | 0.130 |
Why?
|
Flow Cytometry | 4 | 2021 | 5880 | 0.130 |
Why?
|
Nutritional Sciences | 1 | 2017 | 148 | 0.130 |
Why?
|
Proteoglycans | 2 | 1996 | 793 | 0.120 |
Why?
|
HIV | 1 | 2002 | 1587 | 0.120 |
Why?
|
Receptors, Prostaglandin | 1 | 2015 | 54 | 0.120 |
Why?
|
Cell Degranulation | 2 | 2022 | 276 | 0.120 |
Why?
|
Plasma | 1 | 2018 | 583 | 0.120 |
Why?
|
Platelet Activating Factor | 1 | 2015 | 142 | 0.120 |
Why?
|
Antibody Specificity | 1 | 2017 | 1061 | 0.120 |
Why?
|
Collagen | 5 | 1998 | 2616 | 0.120 |
Why?
|
Single-Cell Analysis | 3 | 2021 | 2536 | 0.120 |
Why?
|
Ribonucleases | 1 | 1995 | 265 | 0.120 |
Why?
|
RNA, Messenger | 7 | 2016 | 12768 | 0.110 |
Why?
|
Integrin alpha4 | 2 | 2006 | 89 | 0.110 |
Why?
|
Eczema | 1 | 2017 | 244 | 0.110 |
Why?
|
Receptors, Thromboxane A2, Prostaglandin H2 | 1 | 2013 | 10 | 0.110 |
Why?
|
Echium | 1 | 2013 | 3 | 0.110 |
Why?
|
Receptors, Interleukin-4 | 2 | 2005 | 65 | 0.110 |
Why?
|
Interleukin-6 | 1 | 2024 | 3225 | 0.110 |
Why?
|
gamma-Linolenic Acid | 1 | 2013 | 16 | 0.110 |
Why?
|
Lipoxygenases | 1 | 2013 | 13 | 0.110 |
Why?
|
Cell Division | 4 | 2004 | 4466 | 0.110 |
Why?
|
Child | 10 | 2024 | 80568 | 0.110 |
Why?
|
Fibronectins | 1 | 1997 | 720 | 0.110 |
Why?
|
Cell Line | 7 | 2020 | 15540 | 0.110 |
Why?
|
Anti-Asthmatic Agents | 1 | 2018 | 572 | 0.110 |
Why?
|
Airway Obstruction | 1 | 2018 | 672 | 0.110 |
Why?
|
Platelet Factor 4 | 1 | 2013 | 131 | 0.110 |
Why?
|
Fibroblasts | 3 | 2024 | 4161 | 0.110 |
Why?
|
Adult | 19 | 2024 | 223088 | 0.100 |
Why?
|
Middle Aged | 18 | 2024 | 223016 | 0.100 |
Why?
|
Receptors, Prostaglandin E, EP1 Subtype | 1 | 2012 | 9 | 0.100 |
Why?
|
Mucins | 1 | 2016 | 568 | 0.100 |
Why?
|
Leukotriene B4 | 1 | 2014 | 281 | 0.100 |
Why?
|
Plant Oils | 1 | 2013 | 199 | 0.100 |
Why?
|
Anticonvulsants | 1 | 2002 | 1919 | 0.100 |
Why?
|
Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 1996 | 890 | 0.100 |
Why?
|
Airway Resistance | 1 | 2013 | 407 | 0.100 |
Why?
|
Disease Models, Animal | 4 | 2012 | 18292 | 0.100 |
Why?
|
ras Guanine Nucleotide Exchange Factors | 1 | 2012 | 34 | 0.100 |
Why?
|
Cross-Over Studies | 1 | 2018 | 2108 | 0.100 |
Why?
|
Respiratory Tract Infections | 1 | 2019 | 1008 | 0.100 |
Why?
|
Staphylococcus aureus | 1 | 2019 | 1422 | 0.090 |
Why?
|
Bronchoconstriction | 1 | 2012 | 141 | 0.090 |
Why?
|
P-Selectin | 1 | 2013 | 598 | 0.090 |
Why?
|
Platelet-Rich Plasma | 1 | 2013 | 180 | 0.090 |
Why?
|
Endoscopy | 1 | 2021 | 1854 | 0.090 |
Why?
|
Phospholipases A2, Secretory | 1 | 2010 | 30 | 0.090 |
Why?
|
Disease Susceptibility | 2 | 2021 | 1787 | 0.090 |
Why?
|
Pyrimidines | 2 | 2011 | 3049 | 0.090 |
Why?
|
Platelet Aggregation Inhibitors | 2 | 2013 | 2769 | 0.090 |
Why?
|
Mice, 129 Strain | 1 | 2011 | 367 | 0.090 |
Why?
|
Risk Reduction Behavior | 1 | 2017 | 1121 | 0.090 |
Why?
|
Macrophage Activation | 1 | 2013 | 552 | 0.090 |
Why?
|
Up-Regulation | 3 | 2020 | 4130 | 0.080 |
Why?
|
Immunoglobulin G | 2 | 2020 | 4555 | 0.080 |
Why?
|
Endothelium, Vascular | 1 | 2002 | 4423 | 0.080 |
Why?
|
Arthritis, Experimental | 1 | 2012 | 288 | 0.080 |
Why?
|
Lymphocytes | 1 | 2017 | 2601 | 0.080 |
Why?
|
Lymphoid Tissue | 1 | 2011 | 444 | 0.080 |
Why?
|
Transcriptional Activation | 2 | 2007 | 1743 | 0.080 |
Why?
|
Diabetes Mellitus, Type 2 | 2 | 2023 | 12235 | 0.080 |
Why?
|
Purinergic P2 Receptor Antagonists | 1 | 2009 | 67 | 0.080 |
Why?
|
Amino Acid Sequence | 4 | 2023 | 13398 | 0.080 |
Why?
|
Lipopolysaccharides | 1 | 2017 | 2213 | 0.080 |
Why?
|
Aged | 10 | 2024 | 171163 | 0.080 |
Why?
|
Young Adult | 6 | 2021 | 59857 | 0.080 |
Why?
|
Protein Kinase C | 1 | 2013 | 1202 | 0.080 |
Why?
|
HeLa Cells | 2 | 2007 | 3070 | 0.080 |
Why?
|
Metaplasia | 1 | 2009 | 325 | 0.080 |
Why?
|
Receptor Cross-Talk | 1 | 2009 | 118 | 0.080 |
Why?
|
Exanthema | 2 | 2003 | 503 | 0.080 |
Why?
|
Food Labeling | 1 | 2011 | 181 | 0.070 |
Why?
|
STAT1 Transcription Factor | 1 | 2009 | 340 | 0.070 |
Why?
|
Hyperplasia | 2 | 2018 | 1142 | 0.070 |
Why?
|
Cricetulus | 1 | 2009 | 806 | 0.070 |
Why?
|
Cell Adhesion | 3 | 2002 | 3089 | 0.070 |
Why?
|
Guinea Pigs | 1 | 2009 | 1300 | 0.070 |
Why?
|
Histamine | 2 | 2022 | 496 | 0.070 |
Why?
|
Nuclear Proteins | 1 | 2002 | 5782 | 0.070 |
Why?
|
Bone Marrow Transplantation | 1 | 2015 | 2729 | 0.070 |
Why?
|
Neutrophils | 2 | 2024 | 3769 | 0.070 |
Why?
|
Double-Blind Method | 2 | 2018 | 12417 | 0.070 |
Why?
|
MAP Kinase Signaling System | 2 | 2005 | 1489 | 0.070 |
Why?
|
Genetic Predisposition to Disease | 2 | 2024 | 18074 | 0.070 |
Why?
|
Phosphorylation | 3 | 2013 | 8279 | 0.070 |
Why?
|
Rhinitis, Atrophic | 1 | 2006 | 2 | 0.070 |
Why?
|
Rhinomanometry | 1 | 2006 | 6 | 0.070 |
Why?
|
Serine Endopeptidases | 2 | 2020 | 1024 | 0.060 |
Why?
|
Cytoplasmic Granules | 2 | 2001 | 573 | 0.060 |
Why?
|
RNA-Binding Proteins | 2 | 2012 | 1882 | 0.060 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2019 | 4641 | 0.060 |
Why?
|
Coronavirus Infections | 2 | 2020 | 3109 | 0.060 |
Why?
|
Pneumonia, Viral | 2 | 2020 | 3231 | 0.060 |
Why?
|
RNA, Small Interfering | 2 | 2013 | 3419 | 0.060 |
Why?
|
Th17 Cells | 1 | 2012 | 786 | 0.060 |
Why?
|
Bronchi | 1 | 2009 | 843 | 0.060 |
Why?
|
Cyclic AMP Response Element Modulator | 1 | 2005 | 88 | 0.060 |
Why?
|
Immunotherapy | 2 | 2012 | 4746 | 0.060 |
Why?
|
Receptors, Eicosanoid | 1 | 2005 | 12 | 0.060 |
Why?
|
Child, Preschool | 3 | 2017 | 42510 | 0.060 |
Why?
|
Protein Kinase Inhibitors | 3 | 2017 | 5691 | 0.060 |
Why?
|
beta-N-Acetylhexosaminidases | 1 | 2004 | 43 | 0.060 |
Why?
|
Chymases | 1 | 2025 | 84 | 0.060 |
Why?
|
Receptors, Purinergic P2Y1 | 1 | 2004 | 39 | 0.060 |
Why?
|
Tumor Necrosis Factor-alpha | 4 | 2005 | 4342 | 0.060 |
Why?
|
Immunohistochemistry | 4 | 2013 | 11030 | 0.060 |
Why?
|
Nasal Septum | 1 | 2006 | 131 | 0.060 |
Why?
|
Gene Silencing | 1 | 2011 | 1504 | 0.060 |
Why?
|
Respiratory Syncytial Virus Infections | 1 | 2009 | 365 | 0.060 |
Why?
|
Adolescent | 8 | 2020 | 88811 | 0.060 |
Why?
|
Methacholine Chloride | 2 | 2017 | 219 | 0.060 |
Why?
|
CD40 Ligand | 1 | 2006 | 528 | 0.060 |
Why?
|
Drug Therapy, Combination | 2 | 2012 | 6306 | 0.060 |
Why?
|
Lipid Metabolism | 1 | 2012 | 1893 | 0.060 |
Why?
|
Mitochondrial Proteins | 1 | 2010 | 975 | 0.060 |
Why?
|
HIV-1 | 1 | 2001 | 6945 | 0.060 |
Why?
|
Age Factors | 2 | 2020 | 18382 | 0.060 |
Why?
|
Leukocyte Count | 3 | 2015 | 1605 | 0.060 |
Why?
|
Laryngectomy | 1 | 2006 | 245 | 0.060 |
Why?
|
Pulmonary Ventilation | 1 | 2006 | 375 | 0.060 |
Why?
|
Protein Binding | 2 | 2007 | 9296 | 0.060 |
Why?
|
Cell Survival | 2 | 2009 | 5745 | 0.060 |
Why?
|
Molecular Sequence Data | 3 | 2009 | 17596 | 0.050 |
Why?
|
Pandemics | 2 | 2020 | 8721 | 0.050 |
Why?
|
Olfaction Disorders | 1 | 2006 | 223 | 0.050 |
Why?
|
Umbilical Cord | 1 | 2004 | 178 | 0.050 |
Why?
|
Leukocytes, Mononuclear | 2 | 2013 | 1852 | 0.050 |
Why?
|
Microscopy, Immunoelectron | 1 | 2003 | 315 | 0.050 |
Why?
|
Dendritic Cells | 2 | 2013 | 2745 | 0.050 |
Why?
|
Models, Biological | 3 | 2013 | 9443 | 0.050 |
Why?
|
Trichinellosis | 1 | 2002 | 27 | 0.050 |
Why?
|
Trichinella spiralis | 1 | 2002 | 22 | 0.050 |
Why?
|
Gene Expression | 1 | 2015 | 7581 | 0.050 |
Why?
|
Nutritional Status | 1 | 2011 | 1620 | 0.050 |
Why?
|
Immunity | 1 | 2008 | 1000 | 0.050 |
Why?
|
Adoptive Transfer | 2 | 2017 | 827 | 0.050 |
Why?
|
Dose-Response Relationship, Drug | 3 | 2016 | 10727 | 0.050 |
Why?
|
Carbachol | 1 | 2022 | 223 | 0.050 |
Why?
|
Risk Factors | 4 | 2024 | 74850 | 0.050 |
Why?
|
Enzyme Activation | 1 | 2008 | 3583 | 0.050 |
Why?
|
Diagnosis, Differential | 3 | 2010 | 12973 | 0.050 |
Why?
|
Receptors, Neuropeptide | 1 | 2022 | 106 | 0.050 |
Why?
|
Models, Immunological | 1 | 2004 | 517 | 0.050 |
Why?
|
Sulfonylurea Compounds | 1 | 2023 | 220 | 0.050 |
Why?
|
DNA Primers | 2 | 2004 | 2824 | 0.050 |
Why?
|
Diabetes Mellitus | 1 | 2020 | 5889 | 0.050 |
Why?
|
Cell Separation | 2 | 1998 | 1718 | 0.050 |
Why?
|
Umbilical Veins | 1 | 2002 | 422 | 0.050 |
Why?
|
Sequence Analysis, RNA | 2 | 2020 | 2036 | 0.050 |
Why?
|
Antibodies, Monoclonal | 3 | 2009 | 9239 | 0.050 |
Why?
|
Guideline Adherence | 1 | 2011 | 2234 | 0.050 |
Why?
|
Influenza, Human | 2 | 2024 | 1539 | 0.050 |
Why?
|
Monocytes | 2 | 2001 | 2591 | 0.050 |
Why?
|
Phosphoproteins | 1 | 2010 | 2444 | 0.050 |
Why?
|
Apoptosis | 3 | 2004 | 9505 | 0.050 |
Why?
|
Integrin beta Chains | 1 | 2021 | 116 | 0.040 |
Why?
|
Dietary Supplements | 1 | 2013 | 3427 | 0.040 |
Why?
|
Receptors, Cytokine | 1 | 2001 | 257 | 0.040 |
Why?
|
Pulmonary Fibrosis | 1 | 2004 | 503 | 0.040 |
Why?
|
Muscle, Smooth | 1 | 2004 | 931 | 0.040 |
Why?
|
Enzyme Inhibitors | 2 | 2003 | 3716 | 0.040 |
Why?
|
Antigen-Presenting Cells | 1 | 2004 | 960 | 0.040 |
Why?
|
5-Lipoxygenase-Activating Proteins | 2 | 1996 | 24 | 0.040 |
Why?
|
Anti-Allergic Agents | 2 | 2013 | 153 | 0.040 |
Why?
|
Mannose-Binding Lectins | 1 | 2000 | 100 | 0.040 |
Why?
|
E-Selectin | 1 | 2002 | 576 | 0.040 |
Why?
|
Receptors, Interleukin-3 | 1 | 1999 | 29 | 0.040 |
Why?
|
Leukemia | 1 | 2008 | 1522 | 0.040 |
Why?
|
Drug Combinations | 2 | 1996 | 2075 | 0.040 |
Why?
|
Peptide Hydrolases | 1 | 2022 | 608 | 0.040 |
Why?
|
Drug Eruptions | 1 | 2002 | 334 | 0.040 |
Why?
|
Receptors, CCR5 | 1 | 2001 | 491 | 0.040 |
Why?
|
Clinical Trials as Topic | 1 | 2015 | 8037 | 0.040 |
Why?
|
Receptor, Insulin | 1 | 2023 | 837 | 0.040 |
Why?
|
HIV Infections | 2 | 2020 | 17531 | 0.040 |
Why?
|
Thymidine | 1 | 1998 | 294 | 0.040 |
Why?
|
Mitogen-Activated Protein Kinases | 1 | 2003 | 1239 | 0.040 |
Why?
|
Adenosine Triphosphate | 1 | 2004 | 2001 | 0.040 |
Why?
|
GTP-Binding Proteins | 1 | 2022 | 944 | 0.040 |
Why?
|
Desensitization, Immunologic | 2 | 2014 | 545 | 0.040 |
Why?
|
Phenotype | 3 | 2003 | 16714 | 0.040 |
Why?
|
Immediate-Early Proteins | 1 | 2001 | 444 | 0.040 |
Why?
|
Protein Processing, Post-Translational | 1 | 2005 | 1961 | 0.040 |
Why?
|
Sulfides | 1 | 2018 | 166 | 0.040 |
Why?
|
Serotonin | 1 | 2022 | 1046 | 0.040 |
Why?
|
Chemokine CCL11 | 1 | 1997 | 127 | 0.040 |
Why?
|
Antibodies | 3 | 2020 | 2415 | 0.040 |
Why?
|
Imidazoles | 1 | 2003 | 1164 | 0.040 |
Why?
|
Inflammatory Bowel Diseases | 1 | 2012 | 2430 | 0.040 |
Why?
|
Down-Regulation | 1 | 2004 | 2925 | 0.040 |
Why?
|
Skin Diseases | 1 | 1986 | 1083 | 0.040 |
Why?
|
Integrin alpha4beta1 | 1 | 1997 | 119 | 0.030 |
Why?
|
Bronchial Provocation Tests | 1 | 2017 | 216 | 0.030 |
Why?
|
Guanidines | 1 | 1998 | 194 | 0.030 |
Why?
|
Cyclopropanes | 1 | 2018 | 436 | 0.030 |
Why?
|
Waldenstrom Macroglobulinemia | 1 | 2006 | 1076 | 0.030 |
Why?
|
Sequence Alignment | 1 | 2001 | 2172 | 0.030 |
Why?
|
Calcimycin | 1 | 1996 | 214 | 0.030 |
Why?
|
Stress, Mechanical | 1 | 2002 | 1670 | 0.030 |
Why?
|
Ionophores | 1 | 1996 | 108 | 0.030 |
Why?
|
Biological Specimen Banks | 1 | 2022 | 787 | 0.030 |
Why?
|
Lectins, C-Type | 1 | 2000 | 592 | 0.030 |
Why?
|
Receptors, CXCR4 | 1 | 2001 | 729 | 0.030 |
Why?
|
Phospholipases A2 | 1 | 1996 | 197 | 0.030 |
Why?
|
Cell Death | 1 | 2002 | 1676 | 0.030 |
Why?
|
Receptors, Virus | 1 | 2020 | 650 | 0.030 |
Why?
|
Infant, Newborn | 3 | 2004 | 26380 | 0.030 |
Why?
|
Plasma Cells | 1 | 2020 | 596 | 0.030 |
Why?
|
Prostaglandins D | 1 | 2015 | 27 | 0.030 |
Why?
|
Enzyme Induction | 1 | 1996 | 456 | 0.030 |
Why?
|
Syndrome | 1 | 2002 | 3271 | 0.030 |
Why?
|
Phospholipases A | 1 | 1996 | 204 | 0.030 |
Why?
|
Fatty Acids, Nonesterified | 1 | 2017 | 393 | 0.030 |
Why?
|
Virginia | 1 | 2016 | 115 | 0.030 |
Why?
|
Eosinophil-Derived Neurotoxin | 1 | 1995 | 13 | 0.030 |
Why?
|
Lung Diseases | 1 | 2006 | 1939 | 0.030 |
Why?
|
Eosinophil Peroxidase | 1 | 1995 | 22 | 0.030 |
Why?
|
Stromal Cells | 1 | 2001 | 1332 | 0.030 |
Why?
|
Skin | 1 | 2009 | 4481 | 0.030 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2005 | 2879 | 0.030 |
Why?
|
Base Sequence | 2 | 2004 | 12405 | 0.030 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2003 | 3796 | 0.030 |
Why?
|
Risk Assessment | 1 | 2017 | 24275 | 0.030 |
Why?
|
Peroxidases | 1 | 1995 | 134 | 0.030 |
Why?
|
Cell Communication | 1 | 2002 | 1660 | 0.030 |
Why?
|
Chromosomes, Human, Pair 5 | 1 | 1996 | 386 | 0.030 |
Why?
|
Adrenal Cortex Hormones | 1 | 2003 | 1881 | 0.030 |
Why?
|
Drug Synergism | 1 | 1998 | 1751 | 0.030 |
Why?
|
Cardiovascular Diseases | 1 | 2020 | 15645 | 0.030 |
Why?
|
Membrane Glycoproteins | 2 | 2002 | 3690 | 0.030 |
Why?
|
Neurotoxins | 1 | 1995 | 239 | 0.030 |
Why?
|
Immunization | 1 | 2018 | 1218 | 0.030 |
Why?
|
DNA-Binding Proteins | 2 | 2002 | 9600 | 0.030 |
Why?
|
Culture Media, Conditioned | 1 | 1995 | 520 | 0.030 |
Why?
|
Virus Replication | 1 | 2001 | 2450 | 0.030 |
Why?
|
8,11,14-Eicosatrienoic Acid | 1 | 2013 | 64 | 0.030 |
Why?
|
Epigenesis, Genetic | 2 | 2018 | 3816 | 0.030 |
Why?
|
Prospective Studies | 3 | 2023 | 54807 | 0.030 |
Why?
|
Hematopoiesis | 2 | 2010 | 2060 | 0.030 |
Why?
|
Transfection | 1 | 2001 | 5738 | 0.030 |
Why?
|
Macaca mulatta | 1 | 2020 | 2341 | 0.030 |
Why?
|
Seeds | 1 | 2013 | 124 | 0.030 |
Why?
|
alpha-Linolenic Acid | 1 | 2013 | 145 | 0.030 |
Why?
|
Acetylation | 1 | 2016 | 1054 | 0.030 |
Why?
|
Trans-Activators | 1 | 2002 | 2848 | 0.030 |
Why?
|
Amyloidosis | 2 | 1998 | 883 | 0.030 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2012 | 16039 | 0.020 |
Why?
|
Cell Nucleus | 1 | 2001 | 2864 | 0.020 |
Why?
|
Forced Expiratory Volume | 1 | 2017 | 1828 | 0.020 |
Why?
|
Calcium | 2 | 2013 | 5769 | 0.020 |
Why?
|
Interleukin-1 | 3 | 2001 | 1242 | 0.020 |
Why?
|
Capillary Permeability | 1 | 2015 | 769 | 0.020 |
Why?
|
Transcription Factors | 2 | 2002 | 12129 | 0.020 |
Why?
|
Pyridines | 1 | 2003 | 2885 | 0.020 |
Why?
|
Antigens, CD | 1 | 2002 | 4023 | 0.020 |
Why?
|
Edema | 1 | 2015 | 759 | 0.020 |
Why?
|
T-Lymphocytes | 2 | 2013 | 10256 | 0.020 |
Why?
|
Staining and Labeling | 1 | 1995 | 1072 | 0.020 |
Why?
|
Tetradecanoylphorbol Acetate | 1 | 2012 | 822 | 0.020 |
Why?
|
Hypoglycemic Agents | 1 | 2023 | 3106 | 0.020 |
Why?
|
Chimera | 1 | 2012 | 455 | 0.020 |
Why?
|
Cyclic AMP Response Element-Binding Protein | 1 | 2013 | 501 | 0.020 |
Why?
|
Proto-Oncogene Proteins c-fos | 1 | 2013 | 576 | 0.020 |
Why?
|
Histone Deacetylase Inhibitors | 1 | 2016 | 779 | 0.020 |
Why?
|
Dermatophagoides pteronyssinus | 1 | 2010 | 11 | 0.020 |
Why?
|
Administration, Oral | 1 | 2018 | 4016 | 0.020 |
Why?
|
Fatty Acids, Unsaturated | 1 | 2013 | 539 | 0.020 |
Why?
|
T-Lymphocytes, Regulatory | 1 | 2024 | 3111 | 0.020 |
Why?
|
Administration, Intranasal | 1 | 2012 | 482 | 0.020 |
Why?
|
Nerve Tissue Proteins | 1 | 2022 | 4394 | 0.020 |
Why?
|
Carcinogens | 1 | 2012 | 451 | 0.020 |
Why?
|
Eicosapentaenoic Acid | 1 | 2013 | 565 | 0.020 |
Why?
|
Superoxides | 2 | 2001 | 382 | 0.020 |
Why?
|
Case-Control Studies | 2 | 2018 | 22228 | 0.020 |
Why?
|
Mycobacterium tuberculosis | 1 | 2020 | 1909 | 0.020 |
Why?
|
Calcium Signaling | 1 | 2013 | 733 | 0.020 |
Why?
|
Gene Knockdown Techniques | 1 | 2013 | 1601 | 0.020 |
Why?
|
Fluorescent Antibody Technique | 1 | 2013 | 2470 | 0.020 |
Why?
|
Isoenzymes | 1 | 2013 | 1688 | 0.020 |
Why?
|
Mice, Inbred Strains | 1 | 2011 | 1769 | 0.020 |
Why?
|
Chronic Disease | 1 | 2023 | 9351 | 0.020 |
Why?
|
Chemokine CCL1 | 1 | 2007 | 22 | 0.020 |
Why?
|
Receptors, CCR8 | 1 | 2007 | 28 | 0.020 |
Why?
|
Survival Analysis | 1 | 2020 | 10086 | 0.020 |
Why?
|
Gene Expression Profiling | 1 | 2003 | 9525 | 0.020 |
Why?
|
Renal Dialysis | 1 | 1997 | 1791 | 0.020 |
Why?
|
Rats, Inbred WKY | 1 | 2007 | 150 | 0.020 |
Why?
|
Neutrophil Infiltration | 1 | 2010 | 393 | 0.020 |
Why?
|
Massachusetts | 1 | 2020 | 8882 | 0.020 |
Why?
|
Transcription, Genetic | 2 | 2018 | 7599 | 0.020 |
Why?
|
Chemotaxis, Leukocyte | 1 | 2010 | 656 | 0.020 |
Why?
|
Tuberculosis | 1 | 2020 | 2009 | 0.020 |
Why?
|
Dust | 1 | 2010 | 489 | 0.020 |
Why?
|
Respiratory Function Tests | 1 | 2012 | 1692 | 0.020 |
Why?
|
Intensive Care Units | 1 | 2020 | 3799 | 0.020 |
Why?
|
Carrier Proteins | 2 | 1996 | 4909 | 0.020 |
Why?
|
Mucoproteins | 1 | 2006 | 49 | 0.020 |
Why?
|
Sex Factors | 1 | 2020 | 10611 | 0.020 |
Why?
|
Acute Lung Injury | 1 | 2010 | 377 | 0.020 |
Why?
|
Comorbidity | 1 | 2020 | 10575 | 0.020 |
Why?
|
Benzamides | 1 | 2011 | 1376 | 0.020 |
Why?
|
Methods | 1 | 1986 | 1061 | 0.020 |
Why?
|
Histones | 1 | 2016 | 2590 | 0.020 |
Why?
|
Trachea | 1 | 2011 | 1091 | 0.020 |
Why?
|
Spleen | 1 | 2011 | 2294 | 0.020 |
Why?
|
Electronic Health Records | 1 | 2022 | 4863 | 0.020 |
Why?
|
Antigen Presentation | 1 | 2010 | 1250 | 0.010 |
Why?
|
Aged, 80 and over | 2 | 2020 | 59496 | 0.010 |
Why?
|
Promoter Regions, Genetic | 1 | 2016 | 5784 | 0.010 |
Why?
|
Immunophenotyping | 1 | 2009 | 1865 | 0.010 |
Why?
|
Glycosylation | 2 | 1998 | 1099 | 0.010 |
Why?
|
Retrospective Studies | 2 | 2023 | 81537 | 0.010 |
Why?
|
Fatty Acids, Omega-3 | 1 | 2013 | 1399 | 0.010 |
Why?
|
Body Mass Index | 1 | 2022 | 13042 | 0.010 |
Why?
|
Pedigree | 1 | 2011 | 4535 | 0.010 |
Why?
|
Cell Culture Techniques | 1 | 2011 | 1650 | 0.010 |
Why?
|
Blotting, Western | 1 | 2011 | 5019 | 0.010 |
Why?
|
Receptors, Immunologic | 2 | 2001 | 1415 | 0.010 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2010 | 4563 | 0.010 |
Why?
|
Prevalence | 1 | 2020 | 15828 | 0.010 |
Why?
|
Receptors, Interleukin-13 | 1 | 2002 | 13 | 0.010 |
Why?
|
Interleukin-13 Receptor alpha1 Subunit | 1 | 2002 | 23 | 0.010 |
Why?
|
Boston | 1 | 2016 | 9334 | 0.010 |
Why?
|
Kidney Transplantation | 1 | 1998 | 4277 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2020 | 15878 | 0.010 |
Why?
|
Coculture Techniques | 1 | 2006 | 1336 | 0.010 |
Why?
|
STAT6 Transcription Factor | 1 | 2002 | 196 | 0.010 |
Why?
|
DNA Methylation | 1 | 2016 | 4424 | 0.010 |
Why?
|
Receptors, Interleukin | 1 | 2002 | 243 | 0.010 |
Why?
|
Early Growth Response Protein 1 | 1 | 2001 | 132 | 0.010 |
Why?
|
Fas Ligand Protein | 1 | 2001 | 214 | 0.010 |
Why?
|
Larva | 1 | 2002 | 511 | 0.010 |
Why?
|
Hospitalization | 1 | 2020 | 10810 | 0.010 |
Why?
|
Acid Phosphatase | 1 | 2000 | 137 | 0.010 |
Why?
|
Intracellular Membranes | 1 | 2001 | 386 | 0.010 |
Why?
|
Vacuoles | 1 | 2000 | 224 | 0.010 |
Why?
|
Cell Line, Tumor | 1 | 2015 | 17060 | 0.010 |
Why?
|
Tumor Cells, Cultured | 1 | 2006 | 6101 | 0.010 |
Why?
|
HLA-DR Antigens | 1 | 2000 | 608 | 0.010 |
Why?
|
Cell Size | 1 | 2000 | 626 | 0.010 |
Why?
|
Procollagen | 1 | 1998 | 189 | 0.010 |
Why?
|
Recombinant Fusion Proteins | 1 | 2006 | 3733 | 0.010 |
Why?
|
Microscopy, Electron | 1 | 2000 | 2543 | 0.010 |
Why?
|
Antigens, Surface | 1 | 2001 | 1616 | 0.010 |
Why?
|
Pediatrics | 1 | 2011 | 3609 | 0.010 |
Why?
|
Hybrid Cells | 1 | 1996 | 420 | 0.010 |
Why?
|
Spectrometry, Fluorescence | 1 | 1998 | 694 | 0.010 |
Why?
|
Restriction Mapping | 1 | 1996 | 848 | 0.010 |
Why?
|
Quality of Life | 1 | 2017 | 13463 | 0.010 |
Why?
|
Lysosomes | 1 | 2001 | 932 | 0.010 |
Why?
|
Epidermal Growth Factor | 1 | 1998 | 697 | 0.010 |
Why?
|
Kidney Failure, Chronic | 2 | 1998 | 2504 | 0.010 |
Why?
|
Sequence Homology, Nucleic Acid | 1 | 1996 | 1056 | 0.010 |
Why?
|
Immunoblotting | 1 | 1998 | 1643 | 0.010 |
Why?
|
Rodentia | 1 | 1996 | 263 | 0.010 |
Why?
|
Glucocorticoids | 1 | 2003 | 2155 | 0.010 |
Why?
|
Introns | 1 | 1996 | 965 | 0.010 |
Why?
|
B-Lymphocytes | 1 | 2006 | 4782 | 0.010 |
Why?
|
Sequence Homology, Amino Acid | 1 | 1996 | 2743 | 0.010 |
Why?
|
Rats | 1 | 2007 | 23708 | 0.010 |
Why?
|
Receptors, Cell Surface | 1 | 2000 | 2814 | 0.010 |
Why?
|
Cloning, Molecular | 1 | 1996 | 4163 | 0.010 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 1998 | 3801 | 0.010 |
Why?
|
Exons | 1 | 1996 | 2393 | 0.010 |
Why?
|
In Situ Hybridization, Fluorescence | 1 | 1996 | 2510 | 0.010 |
Why?
|
Analysis of Variance | 1 | 1998 | 6202 | 0.010 |
Why?
|
Cohort Studies | 1 | 2012 | 41680 | 0.000 |
Why?
|
Time Factors | 2 | 2001 | 40097 | 0.000 |
Why?
|
Chromosome Mapping | 1 | 1996 | 4617 | 0.000 |
Why?
|
Polymerase Chain Reaction | 1 | 1996 | 6058 | 0.000 |
Why?
|
Glucose | 1 | 1998 | 4335 | 0.000 |
Why?
|